Search

everythinglearnresearchcommunity

for

Search:↓

Pentoxifylline is a safe and effective alternative to triamcinolone acetonide for treating localized alopecia areata.

The man was diagnosed with stage III multiple myeloma and treated to improve kidney function.

Doxycycline helps prevent skin issues from erlotinib in lung cancer patients.

A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.

Combining light therapy, acid, and microneedling improves hair regrowth in stubborn hair loss cases.

FTY720 helps transplanted fat survive better by reducing immune rejection and improving blood vessel growth.

Alkylating agents can kill cancer cells but may cause skin and allergic reactions.

Cyclophosphamide is preferred for severe cases in pediatric rheumatology and nephrology despite its side effects.

A woman developed a hair disorder after a bone marrow transplant, which improved with treatment.

Upadacitinib may cause hair loss.

Simvastatin/ezetimibe may help some patients with severe alopecia areata regrow hair.

The gel improves hair regrowth and reduces irritation in alopecia areata treatment.

Topical tofacitinib may help regrow hair in children with alopecia totalis.

Bexarotene 1% topical gel helped some patients with alopecia areata regrow hair.

Ruxolitinib helps regrow hair in alopecia areata by blocking inflammation, reducing stress, and controlling cell death.

Docetaxel chemotherapy causes more long-term hair loss and dissatisfaction than paclitaxel.

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

Deuruxolitinib effectively improves hair regrowth in alopecia areata but requires monitoring for side effects.

Azathioprine may help treat severe alopecia areata, but more research is needed.

AZD6244 treatment causes skin aging effects by depleting skin stem cells.

Irradiating the whole central nervous system can lead to over 50% of patients with cerebellar medulloblastoma surviving three years.

New treatments targeting the JAK signaling pathway, especially JAK inhibitors, show promise for alopecia areata.

Continued ritlecitinib treatment can improve hair regrowth in some alopecia areata patients who initially don't respond.

Patients with alopecia areata face challenges accessing Janus kinase inhibitors, but some see positive results.

Docetaxel is safe and works well for older people with cancer, with manageable side effects.

Dupilumab led to complete hair regrowth and improved skin condition in a young man with severe eczema and hair loss.

Anti-TNF-α therapy may increase the risk of developing alopecia areata, especially in those with a history of autoimmune disease.

Microinfusion of methotrexate can help treat frontal fibrosing alopecia.